IL2 and systemic lupus erythematosus: von Spee-Mayer von Spee-Mayer C C Siegert Siegert E E Abdirama Abdirama D D Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus Ann.